Endocrine Abstracts

Diabetes is the leading cause of end stage renal failure. So, identifying patients at risk and intensifying management of blood pressure, lipids and glycaemic control can reduce and delay progression to organ replacement therapy. The aim of our study was to determine whether our pilot 3 monthly joint diabetes-renal clinics set up in April 2018 was able to achieve targets outlined by national guidelines and whether patient satisfaction and improved outcomes could lead to furthe...